BXB and COH on Watch as ASX 50 and ASX 100 Performers Shift Gears

June 23, 2025 04:42 PM AEST | By Team Kalkine Media
 BXB and COH on Watch as ASX 50 and ASX 100 Performers Shift Gears
Image source: Shutterstock

Highlights

  • Brambles Ltd expands CHEP footprint with strong operational model

  • Cochlear Ltd maintains global leadership in implantable hearing solutions

  • Market focus turns to fundamentals and corporate growth trends

Brambles Ltd (ASX:BXB) and Cochlear Ltd (ASX:COH) have been drawing attention across the ASX 50 and ASX 100 indices. Brambles' recent momentum in the industrial logistics space and Cochlear's consistent development within the global medical device sector are shaping the broader outlook for their respective segments.

Both companies operate in distinct industries yet share a common thread in their ability to maintain global relevance through innovation and robust business frameworks.

Brambles Ltd Strengthens Supply Chain Platform

Brambles Ltd is recognised for operating the world’s largest network of reusable pallets, crates, and containers through its CHEP brand. The company provides an integral link in the logistics value chain by enabling efficient movement of goods across retailers and manufacturers on a global scale.

The CHEP business model allows Brambles to generate recurring revenue through equipment hire, which forms the backbone of its financial structure. Operating across multiple international regions, the company’s strength lies in its scalability and sustainability-driven logistics solutions.

Metrics often reviewed for such a business include operational gearing, long-term returns, and shareholder distribution strategies. Brambles continues to be highlighted for its consistent cash-generative structure and longstanding position as a mature industrial business within the Australian corporate landscape.

Cochlear Ltd Sustains Global Medical Device Leadership

Cochlear Ltd designs and manufactures hearing implant devices, supporting patients with various degrees of hearing impairment. Founded in Sydney and operating globally, the company distributes its products across more than 50 countries and employs a workforce with expertise in advanced audiology and surgical innovation.

The medical technology segment is marked by its emphasis on research, product lifecycle development, and sustained growth via medical adoption. Cochlear's focus remains on expanding its portfolio and service reach, backed by technology integration and clinical application.

Financial metrics often referenced for this type of company include revenue trajectory, profit expansion, and return efficiency over multiple periods. Cochlear has demonstrated resilient performance, underpinned by the increasing demand for hearing solutions and its strategic market positioning.

Valuation Perspectives Remain Tied to Fundamentals

While Brambles may be viewed as an established logistics infrastructure provider, Cochlear stands in contrast as a health technology innovator. The financial performance of both companies reflects different corporate life cycles — one focused on income generation and infrastructure efficiency, and the other on product expansion and market penetration.

Market observers often turn to measurements such as dividend yield performance for companies like Brambles, aligned with recurring income profiles. For companies in Cochlear’s sector, the emphasis often shifts toward sustained growth metrics and capital reinvestment efficiency.

As both stocks remain influential within the broader ASX landscape, the performance of Brambles Ltd (ASX:BXB) and Cochlear Ltd (ASX:COH) continues to be of interest across institutional and sectoral reviews.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.